The paclitaxel-eluting PTCA-balloon catheter in coronary artery disease to treat chronic total occlusions.

Trial Profile

The paclitaxel-eluting PTCA-balloon catheter in coronary artery disease to treat chronic total occlusions.

Completed
Phase of Trial: Phase II

Latest Information Update: 17 Jul 2014

At a glance

  • Drugs Paclitaxel (Primary)
  • Indications Coronary artery disease; Coronary artery restenosis; Myocardial ischaemia
  • Focus Therapeutic Use
  • Acronyms PEPCAD-CTO
  • Most Recent Events

    • 07 Jun 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 23 Aug 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 23 Jan 2009 Planned end date changed from 1 Aug 2010 to 1 Sep 2014.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top